Skip to main content
. 2015 Jun 25;10(6):e0131658. doi: 10.1371/journal.pone.0131658

Fig 2. Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) for the prediction of (A) significant fibrosis (≥F2), (B) severe fibrosis (≥F3), and (C) cirrhosis (F4).

Fig 2